Search Results - "Dealey, Robert"

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol by Attard, Gerhardt, Murphy, Laura, Clarke, Noel W, Jones, Robert J, Cook, Adrian, Brawley, Chris, Amos, Claire L, Atako, Nafisah, Chowdhury, Simon, Russell, J Martin, Gilson, Clare, Rush, Hannah, Bowen, Jo, O'Sullivan, Joe M, Birtle, Alison, Gale, Joanna, Srihari, Narayanan, Tanguay, Jacob, Gray, Emma, Alzoueb, Mymoona, Parikh, Omi, Robinson, Angus, Syndikus, Isabel, Wylie, James, Thalmann, George, Dearnaley, David P, Mason, Malcolm D, Gilbert, Duncan, Sydes, Matthew R, Brown, Louise C, Parmar, Mahesh K B, Jones, Elin, Hyde, Katherine, Glen, Hilary, Needleman, Sarah, McGovern, Ursula, Sheehan, Denise, Paisey, Sangeeta, Shaffer, Richard, Beresford, Mark, Malik, Zafar, Zarkar, Anjali, Porfiri, Emilio, Brock, Sue, Bahl, Amit, Smith-Howell, Mike, Woodward, Cathryn, Phan, Mau-Don, Mazhar, Danish, Hamid, Abdel, Ibrahim, Azman, Muthukumar, Dakshinamoorthy, Worlding, Jane, Kagzi, Mohammed, Pezaro, Carmel, Keng-Koh, Pek, McLaren, Duncan, Gupta, Nishi, Boussios, Stergios, Taylor, Henry, Perna, Carla, Grant, Warren, Sabharwal, Ami, Hofmann, Uschi, Dealey, Robert, Brierly, Robert, Capaldi, Lisa, Vivekanandan, Sindu, Tipples, Karen, Afshar, Mehran, Brulinski, Patryk, Sangar, Vijay, Peedell, Clive, Mullassery, Viwod, Protheroe, Andrew, Tarver, Kathryn, Gibbs, Stephanie, Khan, Mohammad Muneeb, Hingorani, Mohan, Crabb, Simon, Bhalla, Neeraj, Logue, John, Leaning, Darren, Vengalil, Salil, Ford, Daniel, Walker, Georgina, Shaheen, Ahmed, Chan, Andrew, Ahmed, Imtiaz, Hilman, Serena, Sayers, Ian, Porter, Tim, Joseph, Joji, Rentsch, Cyrill, Roggero, Enrico, Beyer, Jörg, Strebel, Raeto, Engeler, Daniel, John, Hubert, Durr, Donat

“…Men with high-risk non-metastatic prostate cancer are treated with androgen-deprivation therapy (ADT) for 3 years, often combined with radiotherapy. We…”
Get full text

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol by Attard, Gerhardt, Murphy, Laura, Sachdeva, Ashwin, Jones, Craig, Hoyle, Alex, Cross, William, Parker, Christopher C, Cook, Adrian, Gilson, Clare, Rush, Hannah, Abdel-Aty, Hoda, Amos, Claire L, Murphy, Claire, Chowdhury, Simon, Malik, Zafar, Parkar, Nazia, Pugh, Cheryl, Pezaro, Carmel, Grant, Warren, Saxby, Helen, Birtle, Alison, Thomas, Carys, Tanguay, Jacob, Parikh, Omi, Cathomas, Richard, Brown, Michael D, Jain, Yatin, Dearnaley, David P, Mason, Malcolm D, Millman, Robin, Sydes, Matthew R, Parmar, Mahesh K B, James, Nicholas D, Hyde, Katherine, Glen, Hilary, McGovern, Ursula, Beresford, Mark, Malik, Zafar, Lee, Ling, Sreenivasan, Thiagarajan, Brock, Sue, Brown, Simon, Smith-Howell, Mike, Phan, Mau-Don, Narahari, Krishna, Tanguay, Jacob, Douglas, Fiona, Kumar, Anil, Simms, Matthew, Worlding, Jane, Tran, Anna, Pezaro, Carmel, Sivoglo, Virgil, Masters, Benjamin, Manetta, Caroline, McLaren, Duncan, Taylor, Henry, Perna, Carla, Melcher, Lucinda, Grant, Warren, Dealey, Robert, McPhail, Neil, Brierly, Robert, Sidek, Norma, Whelan, Peter, Robson, Peter, Falconer, Alison, Rudman, Sarah, Vivekanandan, Sindu, Mullessey, Vinod, Vilarino-Varela, Maria, Khoo, Vincent, Sangar, Vijay, Hoskin, Peter, Mullassery, Viwod, Sundar, Santhanam, Khan, Yakhub, Conroy, Ruth, Carser, Judith, Rogers, Paul, Tarver, Kathryn, Gibbs, Stephanie, Khan, Mohammad Muneeb, Hingorani, Mohan, Alameddine, Manal, Hughes, Robert, Logue, John, Vengalil, Salil, Khan, Omar, Ahmed, Imtiaz, Nikapota, Ashok, Bloomfield, David, Rentsch, Cyrill, Pereira Mestre, Ricardo, Roggero, Enrico, Borner, Markus, Berthold, Dominik, Engeler, Daniel, John, Hubert, Popescu, Razvan

“…Abiraterone acetate plus prednisolone (herein referred to as abiraterone) or enzalutamide added at the start of androgen deprivation therapy improves outcomes…”
Get full text